Form 4: CareDx Director Michael Goldberg Acquires Shares in Automatic Quarterly Grant

Director Michael Goldberg acquired 856 shares of CareDx, Inc. common stock on January 6, 2025, through an automatic quarterly grant in lieu of cash compensation.

Summary

• Michael Goldberg, a director of CareDx, Inc., acquired 856 shares of common stock on January 6, 2025.
• The acquisition was an automatic quarterly grant in lieu of cash compensation, as per the issuer's Outside Director Compensation Policy.
• Following the transaction, Goldberg directly owns 139,928 shares of CareDx common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction (director share acquisition) that indicates alignment of interests but doesn't necessarily signal significant changes in the company's outlook.

Positives

• The acquisition reflects continued director alignment with company performance.

Industry Context

Director share acquisitions are common and often viewed positively, indicating confidence in the company's future prospects. This is a standard part of director compensation packages in many publicly traded companies.

Comparison to Industry Standards

• Director compensation packages often include equity grants to align director interests with shareholder value, similar to practices at companies like Exact Sciences (EXAS) and Natera (NTRA).
• The size of the grant is typical for non-employee director compensation, comparable to grants seen at peer companies in the diagnostics and biotechnology sectors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with shareholder value.

Key Dates